Impacted by higher tax outgo, pharma major Aurobindo Pharma’s posted a 12% drop in consolidated net profit for the fourth quarter ended March 31, 2023, at Rs 506 crore as compared to Rs 576 crore in the corresponding quarter of financial year 2021-22.https://ift.tt/VFItOX9
from Business News: Latest News on Business, Stock Markets, Financial News, India Business & World Business News https://ift.tt/bPuGFlB
0 Comments:
Post a Comment